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Abstract
Background: ‘‘TBDx’’ is an innovative smear microscopy system that automatically loads slides onto a microscope, focuses
and digitally captures images and then classifies smears as positive or negative using computerised algorithms.
Objectives: To determine the diagnostic accuracy of TBDx, using culture as the gold standard, and compare this to a
microscopist’s diagnostic performance.
Methods: This study is nested within a cross-sectional study of tuberculosis suspects from South African gold mines. All
tuberculosis suspects had one sputum sample collected, which was decontaminated prior to smear microscopy, liquid
culture and organism identification. All slides were auramine-stained and then read by both a research microscopist and by
TBDx using fluorescence microscopes, classifying slides based on the WHO classification standard of 100 fields of view (FoV)
at 4006magnification.
Results: Of 981 specimens, 269 were culture positive for Mycobacterium tuberculosis (27.4%). TBDx had higher sensitivity
than the microscopist (75.8% versus 52.8%, respectively), but markedly lower specificity (43.5% versus 98.6%, respectively).
TBDx classified 520/981 smears (53.0%) as scanty positive. Hence, a proposed hybrid software/human approach that
combined TBDx examination of all smears with microscopist re-examination of TBDx scanty smears was explored by
replacing the ‘‘positive’’ result of slides with 1–9 AFB detected on TBDx with the microscopist’s original reading. Compared
to using the microscopist’s original results for all 981 slides, this hybrid approach resulted in equivalent specificity, a slight
reduction in sensitivity from 52.8% to 49.4% (difference of 3.3%; 95% confidence interval: 0.2%, 6.5%), and a reduction in the
number of slides to be read by the microscopist by 47.0%.
Discussion: Compared to a research microscopist, the hybrid software/human approach had similar specificity and positive
predictive value, but sensitivity requires further improvement. Automated microscopy has the potential to substantially
reduce the number of slides read by microscopists.
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Introduction
Despite early indications of a global reduction in tuberculosis
incidence, in 2010 there were still an estimated 8.8 million incident
cases and 1.5 million deaths worldwide [1]. Smear microscopy
remains the mainstay of tuberculosis diagnosis in most high-
burden settings, with 2.6 million new sputum smear-positive cases
of pulmonary tuberculosis reported to the World Health
Organisation in 2010 [1]. However, the sensitivity of smear
microscopy is highly variable [2] for a variety of reasons, including
poorly trained staff working long hours with a near absence of
quality assurance [3,4]. Mycobacterial culture remains the gold
standard for diagnosing TB; however, liquid culture is associated
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with high levels of contamination, solid culture is slower and less
sensitive, and in general the use of culture is limited to specialised
laboratories with appropriate biosafety infrastructure [5,6].
Although new technologies, such as the Xpert MTB/RIF test
[7], are becoming available it is unlikely that these technologies
will be affordable replacements for smear microscopy in many
high burden settings for the foreseeable future and some may not
be suitable for treatment monitoring [8]. ‘‘TBDx’’ is a new smear
microscopy system that automatically: loads slides onto the stage of
a conventional fluorescence microscope; focuses; digitally captures
images; and then uses computerised algorithms to count the
number of acid-fast bacilli (AFBs) detected to classify smears as
positive or negative (Figure 1).
The aim of this study was to describe the performance
characteristics and microscopist’s workload of a diagnostic
algorithm using TBDx alone, or in combination with a micros-
copist, using mycobacterial culture results as the gold standard.
Methods
Ethics statement
This study was nested within a cross-sectional study to evaluate
the Hain MTBDRplus diagnostic test (as detailed below). Informed
consent was obtained from all participants for this original
evaluation and this consent allowed for use of the collected
sputum for the performance of multiple, unspecified, tuberculosis
diagnostic tests for research purposes. This consent was obtained
as written consent or, for illiterate participants, witnessed oral
consent. For illiterate participants, there was an impartial witness
present during the consenting process, who then signed the
relevant witness section of the consent form. Ethics approval was
obtained for this secondary use of the study data from the same
ethics committees that approved the original evaluation, namely:
the University of KwaZulu Natal, South Africa; London School of
Hygiene and Tropical Medicine, UK; and Johns Hopkins
University School of Medicine, USA. All ethics committees
approved the consent form, including the section on the use of
witnessed oral consent for illiterate participants, at the beginning
of the original evaluation.
Study population
A cross-sectional study of tuberculosis suspects was nested
within a large, cluster randomised trial of community-wide
isoniazid preventive therapy in the South African gold mines
(the ‘‘Thibela TB’’ study [9]), and conducted between November
2008 and January 2010. This study compared the Hain
MTBDRplus diagnostic test to liquid mycobacterial culture and
anti MPB64 antigen-based organism identification [10]. As
described elsewhere, participants were a consecutive sample of
adult tuberculosis suspects identified by clinical and/or radiolog-
ical findings, either through self-presentation at mine health
services, during routine annual chest X-ray screening, or during
screening for active tuberculosis prior to isoniazid preventive
therapy; those already on tuberculosis treatment were excluded
[9,10]. Each participant had one spontaneously expectorated
sputum specimen collected at the time of interview. All slides were
examined by fluorescence microscopy and then stored. This set of
stored slides with microscopy and culture results provided an
opportunity to rapidly evaluate TBDx.
Sample selection
For the TBDx assessment, existing sample information and
slides were selected from participants in the original study [10],
based on the following inclusion criteria: the culture result must
have been either positive for Mycobacterium tuberculosis or negative
(i.e. specimens were excluded if the culture was contaminated or
only positive for mycobacteria other than M. tuberculosis complex).
From those who satisfied these criteria, one thousand specimens
were randomly selected, using stratified random sampling, such
that the same percentage were culture positive for M. tuberculosis as
in the wider sample.
Conventional microbiology methods
As described previously [10], expectorated sputum specimens
were digested and decontaminated using N-acetyl-L-cysteine-
NaOH, centrifuged, and the pellet was suspended in approxi-
mately 1.5 ml of phosphate buffer. For each specimen, a portion of
the sediment was smeared over an area approximately 261 cm on
a glass slide. Smears were completely air-dried in a biological
safety cabinet and then fixed for 2 hours on an electric slide
warmer. Each slide was then stained using auramine O,
decolourised with acid-alcohol, and counterstained with potassium
permanganate. Microscopy was performed within 24 hours by a
single study-dedicated microscopist using an Olympus BHT 100
WATT Mercury Vapour Burner microscope, fitted with an
Olympus Plan 406 objective (406magnification; 0.65 numerical
aperture; 22 fieldnumber) and an Olympus WHN10X/22
eyepiece (106magnification; 22 fieldnumber), giving 4006 visual
magnification. Smears were examined using systematic sweeps,
and a minimum of 100 fields were examined before a smear was
reported as having no AFB observed; the time to read negative
smears was approximately 2–3 minutes per negative smear. Smear
results were quantitated as per WHO recommendations [11]. The
microscopist’s qualifications included approximately 45 years in a
high volume clinical mycobacteriology laboratory. A 0.5 ml
portion of the sediment was inoculated in the BACTEC MGIT
960 system (BD Diagnostic Systems, Sparks, MD) and positive
cultures were confirmed as M. tuberculosis using an anti MPB64
monoclonal antibody assay (Capilia TB, TAUNS Laboratories,
Numazu, Japan).
The research microscopist’s original results were used in this
study. In order to ensure optimal staining before being read by the
TBDx system, all stored slides were re-stained using the method
described above. A quality check was conducted to ensure that
Figure 1. The TBDx system, including microscope, slide rack
and computer system. Label 1: Prior 200 Slide Loader, with 4 slide
cassettes containing 50 slides each. Label 2: Olympus Microscope,
Olympus Camera and Prior Automated Slide Stage. Label 3: Joystick for
manual stage movement. Label 4: Computer running TBDx integration,
detection, and reporting software.
doi:10.1371/journal.pone.0050173.g001
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smear positive slides were not adversely affected by storage or re-
staining. Hence, all slides initially classified as smear positive were
re-read by the same research microscopist; all but a few initially
scanty slides were confirmed to be positive.
Automated microscopy methods
The automated TBDx system (Signature Mapping Medical
Sciences, Inc., a wholly owned subsidiary of Applied Visual
Sciences, Inc., Herndon, Virginia, USA) is based around an
Olympus BX41 microscope with a 106 eyepiece and a 406
objective lens, fitted with an Olympus XC10 colour camera to
acquire the images. The 406objective lens used was an Olympus
UIS2 406 objective lens with the following specifications:
UPLANFL-N (Plan, Semi Apochromat), 0.75 Numerical Aper-
ture, 26.5 Field Number, 0.51 Working Distance and infinity
corrected optical system. The XC10 camera specifications were:
1.4 Megapixel with 2/3 inches sensor size; Peltier Cooled CCD
(10uC at 25uC ambient); resolution of 137661032; bit depth used
at acquisition was 12 bit; and the exposure time is approximately
hundreds of milliseconds fast per field of view. The camera is
mounted via an Olympus U-CMAD3 C mount adapter connected
to an Olympus U-TV1x Direct Image Camera Port which is
mounted onto an Olympus U-TR30 Trinocular tube, giving
optical magnification of 406. This implies that the imaged sample
area is approximately 0.22260.173 mm, or 0.038 mm2 per field of
view. The darkfield setup utilized a 100 W Mercury Lamp
housing using OSRAM bulb and an Olympus U-MWB2 Mirror
Unit (Excitation Filter: 460–490; Emission Filter: 520IF; Dichro-
matic mirror 500).
The slide rack and loader (Prior PL-200 system) is preloaded
with 1–200 slides and then the TBDx system automatically
inventories and selects each slide, inserts it into the stage of the
microscope (a customized version of the Prior Optiscan ES111SL),
focuses the microscope, digitises 100 fields of view at 406
magnification and downloads these data to a computer, which
then uses proprietary algorithms to detect and count AFBs on the
digitised fields of view. Each of the 100 fields of view is analysed by
TBDx, regardless of the number of AFBs detected on previously
examined fields of view for that smear. Slides with no AFBs
detected by TBDx are then classified as TBDx negative, 1–9 AFBs
as TBDx scanty positive and $1 AFB as TBDx positive. TBDx
reading was done blinded to all other results.
Initial piloting using a subset of slides from an earlier diagnostic
sub-study within the Thibela TB study [6], read by the same
microscopist, suggested that the TBDx system over-reported
scanty positive smears. The TBDx system was therefore config-
ured to present a human microscopist with digitised images from
TBDx scanty slides of each field of view classified by the system to
contain at least one AFB. The microscopist was then asked to
confirm if each potential ‘‘AFB’’ on the digitised image
represented true AFB or not.
Statistical methods
Two analyses comparing diagnostic performances of the TBDx
system to the microscopist were pre-specified: the first using the
original reading from TBDx; and the second using the original
reading from TBDx, with TBDx scanty slides reclassified as
negative if the microscopist read all digitised images of potential
AFBs as negative. Both analyses classified slides as TBDx positive
if the final result showed at least one AFB detected in 100 fields of
view.
The culture results were used as the reference for all calculations
of diagnostic performance, with the denominator for sensitivity
calculations being the number of specimens for which the culture
was positive for M. tuberculosis and the denominator for specificity
calculations being the number of specimens for which the culture
was negative. McNemar’s test was used for comparisons of
sensitivity and specificity between different diagnostic methods.
Fisher’s exact test was used for comparisons of sensitivity and
specificity between different participant characteristics (i.e. smear
status, HIV status and prior history of tuberculosis). The binomial
exact method was used for calculation of confidence intervals.
A sample size of 1,000 specimens with 25% culture positivity
would give precision, assuming a 95% confidence interval, around
a 50% sensitivity estimate of 66.2% and precision around a 98%
specificity estimate of 61.0% and so this sample size was chosen.
Results
Participant and laboratory characteristics
Of the 3,165 participants who gave a sputum specimen in the
cross-sectional study [10], 659 (20.8%) were culture positive for M.
tuberculosis, 305 (9.6%) were culture positive for other mycobacte-
rium, 1,751 (55.3%) were culture negative and 450 (14.2%) had a
contaminated culture. From the 2,410 eligible specimens, one
thousand specimens were randomly selected for this evaluation,
nineteen of which could not be included – five slides could not be
found, three were unreadable by fluorescent microscopy, two were
broken or cracked and nine could not be autofocused by the
TBDx system. Hence, there were 981 specimens included in this
evaluation from 963 participants. As would be expected for
members of the South African gold mining workforce, 95.8% of
participants were male, 99.9% were Black Africans, 55.9% were
South African, the median age was 45 years (inter-quartile range:
38 to 51 years) and median time in the workforce was 22 years
(inter-quartile range: 12 to 30 years). Prior history of tuberculosis
was reported by 27.4%. HIV status was self-reported by 411 of
981 participants (41.9%), of whom, 160 (38.9%) reported being
HIV positive; 77 of these 160 (48.1%) reported currently taking
antiretroviral therapy.
Of the 981 specimens, 269 were culture positive for M.
tuberculosis (27.4%). The research microscopist graded 142 of these
269 as smear positive, giving sensitivity of the research microsco-
pist of 52.8% (95% confidence interval [CI]: 46.6%, 58.9%;
Tables 1 and 2). The remaining 712 were culture negative
(72.6%), of which the research microscopist graded 10 as smear
positive, giving specificity of 98.6% (95% CI: 97.4%, 99.3%).
Pre-specified TBDx analyses
The 981 slides were assessed in April 2011 by the TBDx system,
which graded 375 as negative (38.2%), 520 as scanty positive
(53.0%) and 86 as positive (8.8%). Sensitivity was high (75.8%,
95% CI: 70.3%, 80.8%; Table 2), but specificity was low (43.5%,
95% CI: 39.9%, 47.3%). This translated into a similar negative
predictive value [NPV] as the research microscopist, but with a
much lower positive predictive value [PPV] (Table 2). Sensitivity
of TBDx correlated with the smear grading of the research
microscopist, increasing from 58.3% among smear negative
specimens (as graded by the research microscopist), to 62.5% for
scanty specimens, 75.8% for 1+ specimens, 96.9% for 2+
specimens and 100% for 3+ specimens (Fisher’s exact test p-value
,0.001).
Those participants who self-reported as HIV infected had
similar sensitivity of TBDx as those who self-reported as HIV
uninfected (HIV infected: 40/49= 81.6%; HIV uninfected: 42/
61= 68.9%; p-value = 0.186) as well as similar specificity (HIV
infected: 58/111= 52.3%; HIV uninfected: 79/190=41.6%; p-
value = 0.093). The same pattern was seen for the microscopist’s
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reading for both sensitivity (HIV infected: 24/49= 49.0%; HIV
uninfected: 26/61= 42.6%; p-value = 0.566) and specificity (HIV
infected: 110/111= 99.1%; HIV uninfected: 188/190= 99.0%; p-
value .0.99). Similarly, prior history of tuberculosis did not
markedly affect the sensitivity of TBDx (prior history: 52/
63= 82.5%; no prior history: 151/205= 73.7%; p-value = 0.180)
or the specificity of TBDx (prior history: 97/205= 47.3%; no prior
history: 212/506= 41.9%; p-value = 0.210).
Among the 520 TBDx scanty smears, there were 1,092 digital
images of fields of view in which TBDx detected at least one AFB
(an average of 2.1 digital images per TBDx scanty smear). The
research microscopist’s review of these digital images led to 245 of
the 520 smears (47.1%) being re-graded as negative. This resulted
in a reduction in TBDx sensitivity of 14.1%, but an increase in
TBDx specificity of 29.1% (Table 2).
Optimisation of the TBDx system
The results from the pre-specified TBDx algorithm gave good
sensitivity, but the specificity was too low. As this was a proof of
concept study, various possibilities for optimising the algorithm
were subsequently investigated. Figure 2 shows the impact, on
TBDx sensitivity and specificity, of increasing the number of AFBs
required to define a smear as TBDx positive. To achieve TBDx
specificity equal to that of the research microscopist required
defining the cut-point for positive by TBDx as$8 AFBs per smear
(i.e. smears with 0–7 AFBs classified as negative), thereby dropping
sensitivity to 31.6%. To achieve TBDx sensitivity equal to that of
the research microscopist, while maximising TBDx specificity,
required defining the cut-point for positive by TBDx as $3 AFBs
per smear (i.e. smears with 0–2 AFBs classified as negative). A
TBDx ‘‘scanty’’ smear was therefore redefined as those with 3–9
AFBs.
Among the 149 smears with 3–9 AFBs detected, there were 597
digital images of fields of view in which TBDx detected at least one
AFB. The research microscopist’s review of these digital images
led to 45 of the 149 smears (30.2%) being re-graded as negative.
This hybrid software/human approach gave sensitivity of 48.0%
(95% CI: 41.9%, 54.1%; Table 2 – hybrid approach A) and
specificity of 91.4% (95% CI: 89.1%, 93.4%).
From a qualitative perspective, the microscopist reported
finding it challenging to designate the digital images as ‘‘true
AFB’’ or ‘‘not AFB’’ when visualised in isolation from the rest of
the smear. Hence, three hybrid software/human approaches were
explored that combined TBDx examination of all smears with the
research microscopist examination of a subset of smears: smears
with 0 or 0–1 or 0–2 AFBs (for the three algorithms respectively)
detected by TBDx were classified as definitively negative; smears
with $10 AFBs detected by TBDx were classified as definitively
Table 1. Frequency and percentage distributions of microscopist’s smear status by culture results in the 981 specimens.
Microscopist reading Culture positive for M. tuberculosis (n =269) Culture negative (n =712)
Smear negative 127 (47.2%) 702 (98.6%)
Scanty positive 8 (3.0%) 9 (1.3%)
1+ positive 33 (12.3%) 1 (0.1%)
2+ positive 32 (11.9%) 0
3+ positive 69 (25.7%) 0
doi:10.1371/journal.pone.0050173.t001
Table 2. The sensitivity, specificity, PPV and NPV of various microscopy methods, using culture as the gold standard.
Sensitivity Specificity PPV NPV
FoV reviewed by
microscopist*
Protocol specified (1–9 AFB=TBDx
scanty):
Microscopist 52.8% 98.6% 93.4% 84.7% 98,100
TBDx 75.8% 43.5% 33.7% 82.7% 0
TBDx, with microscopist review of digitised
images from TBDx scanty smears
61.7% 72.6% 46.0% 83.4% 1,092
Hybrid software/human approaches:
A: TBDx, with microscopist review of
digitised images from TBDx scanty smears
(3–9 AFB = TBDx scanty)
48.0% 91.4% 67.9% 82.3% 597
B: TBDx, with microscopist’s original reading
of smears classified as TBDx scanty
(1–9 AFB = TBDx scanty) 49.4% 98.9% 94.3% 83.8% 52,000
(2–9 AFB = TBDx scanty) 45.0% 99.2% 95.3% 82.7% 27,500
(3–9 AFB = TBDx scanty) 42.0% 99.2% 95.0% 81.9% 14,900
PPV =positive predictive value; NPV= negative predictive value; FoV = fields of view.
*Assumed that all smears read by the microscopist had 100 FoV reviewed per slide, as data on exact numbers read for positive smears were not recorded. Exact
numbers of digital images of FoV reviewed were recorded and so these are exact.
doi:10.1371/journal.pone.0050173.t002
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positive; and all smears with 1–9 or 2–9 or 3–9 AFBs (for the three
hybrid approaches respectively) by TBDx were classified as
uncertain requiring examination by the microscopist. To simulate
the potential results for these hybrid approaches (hybrid approach
B in Table 2), smears were not re-read by the microscopist, but
instead the original microscopist reading was used. This approach
gave equivalent specificity to the microscopist’s readings for all
three hybrid approaches. However, there was a trade-off between
sensitivity and workload, with the first hybrid approach giving very
similar sensitivity to the microscopist (49.4% compared to 52.8%,
respectively; exact McNemar’s p-value = 0.035), with almost a
halving of workload from 981 to 520 smears to examine (47.0%
reduction), while the third hybrid approach had lower sensitivity
(42.0% compared to 52.8%, respectively; exact McNemar’s p-
value ,0.001), but with a reduction in workload of 84.8%. These
translated into very similar PPVs and NPVs between the hybrid
approach and the research microscopist (Table 2).
Discussion
This study is the first large-scale evaluation of an automated
microscopy system for tuberculosis in the published literature that
we are aware of. Using the fully automated TBDx system gave
high sensitivity (75.8%), but low specificity (43.5%), when
compared to culture as the gold standard. The low specificity
was due to a large number of smears that TBDx classified as scanty
positive, but were from culture negative specimens. To address this
issue, a hybrid software/human approach was explored in which
TBDx was used to categorise smears as strongly likely to be
negative, strongly likely to be positive, or uncertain and thereby
requiring examination of the smear by the microscopist. This
approach (hybrid approach B) resulted in a greatly reduced
workload for the microscopist while maintaining similar perfor-
mance characteristics to the original microscopist’s reading.
In several previously published studies of automated smear
microscopy, evaluation of the performance characteristics of the
automated system have used expert microscopists as the gold
standard and/or used classification of individual objects as ‘‘true
AFB’’ or ‘‘not AFB’’ as the primary endpoint [12–14]. In contrast,
we have used culture results as the gold standard and we have
chosen the primary endpoint to be classification of the smear as
positive or negative. The use of culture as a gold standard is
important as the automated microscopy system may have detected
AFBs missed by the research microscopist. The use of individual
objects as the primary unit of analysis can result in bias depending
on how these objects were selected for evaluation. Hence, it is
important to use the smear as the primary unit of analysis. In
addition, a diagnosis of tuberculosis is made on the basis of positive
or negative slides and not on recognition of individual AFBs,
adding to the importance of evaluating the reading of smears. Both
our choices of gold standard and primary endpoint represent
important strengths of this study compared to previously published
studies. The comparison of performance characteristics to those of
a microscopist was based on the readings of a very experienced
research microscopist, providing the strongest possible comparison
group. The study also benefitted from a large sample size.
One potential limitation is that this study was conducted in one
setting and relied on smear microscopy interpretation by one
highly experienced microscopist, which may affect generalizability.
However, the TBDx system was not affected by the HIV status or
prior tuberculosis history of the participants from whom sputa
were obtained. In many settings a ‘‘routine’’ microscopist might
well have worse performance characteristics than the study-
dedicated microscopist involved in this project; such a situation is
likely to result in a better comparative performance for TBDx
compared to the microscopist. In the analysis of the hybrid
approach B, the use of the microscopist’s original reading for slides
that were classified as uncertain by TBDx has limitations. In a
non-study setting, such slides may be interpreted differently by a
microscopist who knows that these slides are TBDx scanty positive
as the index of suspicion is likely to be higher, which may have
biased our results towards great specificity and lower sensitivity.
Another limitation is that the clinical data relied on self-report,
including for HIV status. Finally, the choice to optimise the system
for fluorescence microscopy rather than Ziehl-Neelsen may have
led to reduced performance. Although sensitivity is typically higher
for fluorescence microscopy [2], this is driven partly by the greater
ease for the human eye to detect images using light rather than
colour and this may not apply to a computerised system that can
use specific colour channels. Also TBDx may have a faster
processing time using bright field microscopy. Formal data on
feasibility endpoints were not collected in this study. However, the
current training syllabus assumes one day of training for a
microscopist to use the system. Slide processing currently takes
approximately two minutes (one minute for the camera to auto-
focus the slide and one minute to acquire 100 digital fields of view),
allowing a full slide loader of 200 slides to be processed in 6–
7 hours.
A study by Somosko¨vi, et al. used an automated microscopy
system to identify ‘‘suspected AFBs’’ in smears and then presented
the digital images to a microscopist for review [15]. This showed
very good agreement with an entirely manual reading system. A
similar system was used with TBDx whereby images were
reviewed by the microscopist for smears with 3–9 AFBs detected
by TBDx (hybrid approach A). This gave reasonable sensitivity
(48.0%) and greatly improved specificity (91.4%), with only 597
fields of view needing to be examined from 981 slides. However,
the specificity was still sub-optimal and the microscopist reported
difficulty in reviewing individual AFBs rather than also reviewing
fields of view in other areas of the smear to have as a comparator.
If the performance of automated microscopy can equal or
surpass that of an experienced microscopist, it would be useful in
Figure 2. Receiver operating characteristic curve showing the
influence of different cut-offs to define positivity with TBDx
(circles) and contrasted to the research microscopist (dia-
mond). AFB= acid-fast bacilli.
doi:10.1371/journal.pone.0050173.g002
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high volume laboratories, but potentially could also be adapted for
use in smaller laboratories, for example by using the camera and
processing power available in mobile phone technology to capture
and analyse images without the need for more expensive
computers [16]. The TBDx system is already available without
the 200-slide loader and can be configured with an automated
stage of one or four slide inserts, or to allow a microscopist to
manually place a slide on the stage. However, although it is likely
that the results presented here can be improved upon, it may not
be possible to match the performance of an experienced
microscopist with a fully automated system. If this is the case
then one possible use of such a system would be in a hybrid
software/human approach as evaluated here (hybrid approach B).
This would need to have at least equal sensitivity and specificity to
that of a human microscopist (using culture as the gold standard).
An alternative strategy that utilises the high sensitivity, but poor
specificity of fully automated TBDx, would be to reserve the use of
Xpert MTB/RIF tests for specimens classified as positive on
TBDx. Such a strategy could potentially greatly reduce the
number of Xpert MTB/RIF tests required, making the use of the
technology more affordable. With the current performance
characteristics of 76% sensitivity and 42% specificity, Xpert
MTB/RIF confirmation would be required for 63% of specimens.
If specificity could be increased to 70% or 80% (while keeping
sensitivity the same at 76%), the number of specimens requiring
Xpert MTB/RIF confirmation would drop to 43% or 35%, while
still detecting 76% of all culture positive cases. This would allow
for the rational use of an expensive technology such as Xpert
MTB/RIF. Both the combined approaches of TBDx and a
microscopist and TBDx and Xpert MTB/RIF discussed here
suggest potentially important roles for an automated smear
microscopy system that still requires some improvement in test
characteristics before it could fully replace microscopists. The
internal algorithms used by TBDx to classify objects as ‘‘AFB’’ or
‘‘not AFB’’ are being refined to reduce the probability of false
positives by using a stepwise classification algorithm based on a
binary decision tree with feature vectors to remove different types
of false positive ‘‘AFBs’’, which may lead to substantial improve-
ments in performance. The development of these internal
algorithms is being done in different ways to prioritise different
trade-offs of sensitivity and specificity. This will allow different
configurations of TBDx depending on whether it was to be used
for diagnosis (greater specificity) or screening (greater sensitivity).
Overall our findings indicate that TBDx holds promise for
reducing, but probably not eliminating, the burden of manual
microscopy as performed by trained microscopists. Additional
work to explore colour-based staining and revised detection
algorithms is underway and additional studies of TBDx deployed
in field settings are warranted.
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